Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ularitide in Cirrhosis Patients With Refractory Ascites
NCT04311489Phase 2Terminated
- Sponsor
- Aarhus University
- Start
- Aug 2020
- Primary completion
- Nov 2022
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of ularitide in ascites, sponsored by Aarhus University. Started Aug 2020; status: terminated.
02
Drugs
ularitide
03
Conditions
ascites
Beyond the preview
Go deeper on NCT04311489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04311489.